In the case of patient no. 10, the genomic analysis detected four mutations, CDK2A/B and MTAP, involved in proliferation of cancer cells, PBRM1, which is a tumor suppressor reported to predict response in urothelial carcinoma, and PIK3C2G. Here, MTAP is linked to neoplasm.